Artificial Intelligence-Driven Precision Medicine for Triple Negative Breast Cancer: Innovations and Insights in TNBC Management

Author: Kothawade PhD., Sachin Namdeo

Edition: 1

ISBN: 9780443335655

Release Date: 24-10-2025

Package Dimensions: 10.9 x 8.5 x 0.9 inches

Languages: English

Binding: paperback

Number Of Pages: 406

Details: Artificial Intelligence-Driven Precision Medicine for Triple Negative Breast Cancer: Innovations and Insights in TNBC Management is a groundbreaking exploration into the transformative role of artificial intelligence in revolutionizing the management of Triple Negative Breast Cancer (TNBC). In 19 chapters, this comprehensive guide navigates the intersection of cutting-edge technology and healthcare, offering insights that bridge the gap between medical professionals, researchers, and individuals affected by TNBC. Diving into the complexities of TNBC, this book unveils the potential of AI in enhancing diagnostic accuracy, personalizing treatment strategies, and reshaping the landscape of breast cancer care.

From radiomics and genomic data analysis to predictive modeling and patient engagement, each chapter unveils the latest innovations and provides practical applications of AI to empower healthcare practitioners and improve patient outcomes. This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field. Addresses the critical need for a comprehensive resource that demystifies the integration of artificial intelligence in the management of Triple Negative Breast Cancer Explains the fundamentals of Artificial Intelligence, but also demonstrates its tangible impact on improving the diagnosis, treatment, and overall care of Triple Negative Breast Cancer patients Equips healthcare practitioners with the knowledge and tools to make informed decisions based on AI-driven insights Inspires researchers and pharmaceutical professionals to leverage artificial intelligence for accelerated drug discovery, targeted therapies, and continuous advancements in TNBC treatment